Skip to content
GenoLensGenoLens

GALNT2

Chr 1q42.13

polypeptide N-acetylgalactosaminyltransferase 2

Aliases:
GalNAc-T2
MANE:
ENST00000366672.5

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital disorders of glycosylation

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Inherited white matter disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • congenital disorder of glycosylation, type iit

    0.78
  • metabolic syndrome

    0.48
  • familial lipoprotein lipase deficiency

    0.47
  • familial hyperlipidemia

    0.43
  • alcohol drinking

    0.43
  • insomnia

    0.39
  • metabolic dysfunction-associated steatotic liver disease

    0.36
  • coronary artery disorder

    0.36
  • hyperlipidemia

    0.35
  • physical activity

    0.34

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Polypeptide N-acetylgalactosaminyltransferase 2

Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has a broad spectrum of substrates for peptides such as EA2, Muc5AC, Muc1a, Muc1b. Probably involved in O-linked glycosylation of the immunoglobulin A1 (IgA1) hinge region. Involved in O-linked glycosylation of APOC-III, ANGPTL3 and PLTP. It participates in the regulation of HDL-C metabolism (PubMed:27508872, PubMed:32293671)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.